Why Did the Chicken Cross the Road? To Get Antibiotics : A Review of Big Chicken

One of the most pressing aspect of the antibiotic resistance crisis is the role of antibiotics in agriculture and the link with human infections. This is an aspect of the problem that has received mixed treatment in the past. It was clear that agricultural use of antibiotics was a problem but its impact on human infections was debated, not well known, and not conclusive though all doctors probably could recite the statistic that 80% of antibiotics sold in the US were for used in animals. Many people, myself included, focused heavily on the superbugs stalking our hospitals and ICU and thought almost exclusively about infection control and human antibiotic stewardship.

However, with the publication of Big Chicken: The Incredible Story of How Antibiotics Created Modern Agriculture and Changed the Way the World Eats, I suspect things will change. This book written by, in my opinion, the premier science journalist, Maryn McKenna, is something extraordinary. I read books in this genre continually and I can saw that McKenna’s ability to tell a compelling non-fiction story while weaving together history, politics, science, and medicine in a manner that teaches and leaves the reader completely captivated is unrivalled.

Big Chicken, which published in 2017, is much more than a book on unraveling antibiotic use in chickens, who are fed “routine doses of antibiotics on almost every day of their lives.” It is nothing short than a history of the chicken industry in the US — which breeds “for everything but flavor: for abundance, for consistency, for speed” — and it is only by understanding antibiotic use in that context that one can really grasp the issue. This is the book’s chief value.

The book teems with so much good information that it is impossible to capture in a short blog post. Some highlights include:

• How antibiotics facilitated the transformation of grain into muscle making an “active backyard bird into a fast-growing, slow-moving, docile block of protein”. Slaughter weights of chickens have doubled in the past 70 years and can be achieved in half the time due largely to the use of growth promoting antibiotics, which allowed chickens to become more than just egg-layers to most farmers.

• The story of the McNugget

• The use of antibiotic-laced harpoons to shoot whales!

• The questionable role of a Mississippi Democrat congressman

• The change in culture that sparked companies like Chick-fil-A and Perdue to revaluate antibiotic use

The book also has great anecdotes of disease outbreak investigations — one featuring a young Mike Osterholm — and scientific studies that increasingly linked antibiotic use in animals to huma infections. The book also discusses how policy evolved with respect to this issue.

For anyone interested in a great story that traces the roots of a major scientific/medical problem, I highly recommend this book. For those who work in infectious disease, it is required reading (as are all of Maryn McKenna’s books).

Taking on HIV Local Epidemic with Local Epidemiology

World AIDS day is about one week away and I think it is important to thing about progress against this infectious disease. While HIV/AIDS does not grab headlines in the manner of Ebola, foodborne outbreaks, or AFM (acute flaccid myelitis) it is important to realize that it is still very impactful in the US and in the world.

In 2018, though there still remains no feasible cure or vaccine there are a few important tools that have reshaped the way it approached.

One such tool is antiretroviral therapy. Many people realize that effective treatment cocktails have transformed HIV from a death sentence to a manageable chronic illness, but they do more than that. When someone is on antiretroviral therapy and their viral load (the amount of virus detectable in their blood) is undetectable. They are no longer contagious. Undetectable = Untransmittable (U = U). This means that treatment is prevention as those on therapy are unable to infect others.

A second tool, is pre-exposure prophylaxis (PrEP). PrEP is a means of protecting oneself from contracting HIV by taking two antiretroviral medications on a regular basis so if one encounters the virus during an activity such as sex, the drugs prevent infection from taking hold. While not a panacea, it is an unequivocal advance in HIV prevention and its scale up could make a significant dent in new HIV infections.

When most people think of HIV, they think of it is as the global problem that it is. However, the global pandemic is really the aggregation of local cases and outbreaks. In the Pittsburgh area, where I live and practice, there are several groups working to curtail infections locally. One such group, that I am part of, is AIDS Free Pittsburgh. This organization’s aim is to decrease new HIV diagnoses in Allegheny County, in which Pittsburgh is located, by 75% from 2015 levels (142 cases) and eliminate AIDS in the county by 2020.

Recent data shows that their concentrated approach of working with strategic partners to increase testing, increase linkage to care, and enhance PrEP prescribing has been effective. In 2017, just 100 new diagnoses of HIV were made in the county — representing a 30% decrease since the formation of the organization — with 26 new AIDS diagnoses.

Looking at the data, however, there clearly are epidemiological opportunities to further decrease the force of infection in the county. For example, 80% of new infections were in males with 61% being in men who have sex with men — a prime target for PrEP. In fact, it seems the 75% goal could almost be met with prevention activity in this subgroup. Injection drug use accounted for 8% of new infections — another transmission category easily amenable to interdiction through needle exchange.

The point I am trying to make is that the HIV crisis can be addressed in a meaningful way just by looking at one’s local epidemiology and tailoring approaches to address the nuances of the area. Other communities, would do well to learn from the example of AIDS Free Pittsburgh.

Controversies & False Alternatives: A Review of Biosecurity Dilemmas

The field of biosecurity is fairly new and for such a new field it is remarkable that so many scholarly works have appeared. I recently completed reading one such work, Biosecurity Dilemmas: Dreaded Diseases, Ethical Responses, and the Health of Nations by Christian Enemark. The theme of this book, published in 2017, is to “highlight and explain the tension between differing values and interests that are generated or exacerbated by the practice of ‘biosecurity’.”

For those that track the field, it comes as no surprise that tensions exist in the field and a constant risk-benefit calculus is always at play. Biosecurity Dilemmas accurately (but selectively) reflects the tension and is divided into four parts that highlight major debates in the field: “Protect or Proliferate,” “Secure or Stifle,” “Remedy or Overkill,” and “Attention or Neglect. Each of the eight chapters explores in detail important events to concretize the concepts being discussed.

My colleague, Gigi Gronvall, has already reviewed this book for Science and highlighted her concerns regarding the selective attention the book pays to arguable the largest biosecurity issue and the heightened attention given to American programs. As she writes:

Although U.S. biodefense efforts are worthy of critical analysis, they are largely transparent. The book would have benefited from more critical attention to a nation that is not nearly as open and that has a long history of flouting biosecurity norms: Russia.

To not recapitulate her review, I want to focus on one specific aspect of Enemark’s analysis that I do not believe to be valid.

Biosecurity, in its original conception, addresses the threat of intentional infectious disease releas. As such, it must be viewed as a national security issue despite the fact that many actions involved may have substantial overlap with public health and ordinary healthcare activities (e.g. disease surveillance, vaccination, diagnostic testing). However, it is indisputable that gains in biosecurity positively impact and synergize with “ordinary” public health and medical activities, involve many of the same people, and have “all hazards” preparedness implications. What, in my analysis, has happened is that because of these synergies, it becomes easier for people to lose the distinctions and muddle the concepts.

Cashing in on this conflation, Enemark to advocate a “security sensitive” approach that attempts to create a middle way between what he characterizes as the “dispassionately evidence-based” and “people’s dread of being attacked.” This “security sensitive utilitarianism” underlies his call to require that all “civilian biodefense projects…afford protection against natural as well as as intentional infectious disease risks” as measured by a “dual-benefit” test.

What Enemark fails to realize is that government, properly understood, has specific roles that are delegated to it. These roles are limited to the protection of individual rights. Individual rights are violated through the use of physical force or fraud. When it comes to biosecurity this means government’s role is to protect individuals from being endangered by the use of microorganisms or their toxins, just as they do with bullets and bombs. Naturally occuring infectious diseases, outside of quarantine and related matters, are can not really be seen in the same manner. Biosecurity is a core function of government. As such, no “dual-benefit test” or calculation involving natural infections should be performed. Biodefense, whether civilian or military, is a policing function of the government and must be evaluated in that context, not in the context of seasonal influenza, HIV, and non-communicable diseases. While it is ideal when biosecurity is integrated with other overlapping domains, it is still distinct. To construct a false alternative obscures this fact.

Overall, despite my disagreements with the philosophical framework of the book, I believe that those wanting to deepen their understanding of aspects of the field of biosecurity would benefit from the book.